Evidence map›Paper›PMID 35670880›Full record

ArticleWorld journal of urology2022

Reporting and grading of complications for intracorporeal robot-assisted radical cystectomy: an in-depth short-term morbidity assessment using the novel Comprehensive Complication Index

Mikolaj Mendrek, Jorn H Witt, Sergey Sarychev, Nikolaos Liakos, Mustapha Addali, Christian Wagner, Theodoros Karagiotis, Andreas Schuette, Armin Soave, Margit Fisch and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Mikolaj Mendrek *Prostate Center Northwest, Department of Urology, Pediatric Urology and Uro-Oncology, St. Antonius-Hospital, Gronau, Germany. mikolaj.mendrek@gmail.com.ORCID http://orcid.org/0000-0003-1962-6540
Jorn H Witt *Prostate Center Northwest, Department of Urology, Pediatric Urology and Uro-Oncology, St. Antonius-Hospital, Gronau, Germany.
Sergey SarychevDepartment of Urology, Kantonsspital Frauenfeld, Spital Thurgau AG, Frauenfeld, Switzerland.
Nikolaos LiakosProstate Center Northwest, Department of Urology, Pediatric Urology and Uro-Oncology, St. Antonius-Hospital, Gronau, Germany.
Mustapha AddaliDepartment of Urology, Kreisklinikum Siegen, Germany.
Christian WagnerProstate Center Northwest, Department of Urology, Pediatric Urology and Uro-Oncology, St. Antonius-Hospital, Gronau, Germany.
Theodoros KaragiotisProstate Center Northwest, Department of Urology, Pediatric Urology and Uro-Oncology, St. Antonius-Hospital, Gronau, Germany.
Andreas SchuetteProstate Center Northwest, Department of Urology, Pediatric Urology and Uro-Oncology, St. Antonius-Hospital, Gronau, Germany.
Armin SoaveDepartment of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Margit FischDepartment of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Julian ReinischDepartment of Urology, Kantonsspital Frauenfeld, Spital Thurgau AG, Frauenfeld, Switzerland.
Thomas HerrmannDepartment of Urology, Kantonsspital Frauenfeld, Spital Thurgau AG, Frauenfeld, Switzerland.
Malte W VetterleinDepartment of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sami-Ramzi Leyh-BannurahProstate Center Northwest, Department of Urology, Pediatric Urology and Uro-Oncology, St. Antonius-Hospital, Gronau, Germany.
St.-Antonius-Hospital Gronau · DEUniversität Hamburg · DESpital Thurgau (Switzerland) · CHStellenbosch University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess suitability of Comprehensive Complication Index (CCI MATERIALS AND

methodsA total of 128 patients with bladder cancer (BCa) undergoing intracorporeal RARC with pelvic lymph node dissection between 2015 and 2021 were included in a retrospective bi-institutional study, which adhered to standardized reporting criteria. Thirty-day complications were captured according to a procedure-specific catalog. Each complication was graded by the CDC and the CCI

results381 complications were identified in 118 patients (92%). 55 (43%), 43 (34%), and 20 (16%) suffered from CDC grade I-II, IIIa, and ≥ IIIb complications, respectively. 16 (13%), 27 (21%), and 2 patients (1.6%) were reoperated, readmitted, and died within 30 days, respectively. 31 patients (24%) were upgraded to most severe complication (CCI

conclusionThe CCI

Indexed as

RoboticsRobotic Surgical ProceduresUrinary Bladder NeoplasmsUrinary DiversionCystectomyHumansMorbidityPostoperative ComplicationsRetrospective StudiesTreatment OutcomeClavien–Dindo classificationComplication assessmentOutcome reportingQuality improvementUrinary bladder neoplasm

Identifiers

PMID35670880
OpenAlexW4281687429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.